According to Karuna Therapeutics's latest financial reports the company has ยฃ1.02 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | ยฃ0.99 B | 6.68% |
2022-12-31 | ยฃ0.92 B | 153.88% |
2021-12-31 | ยฃ0.36 B | 54.76% |
2020-12-31 | ยฃ0.23 B | -20.37% |
2019-12-31 | ยฃ0.29 B | 2614.34% |
2018-12-31 | ยฃ10.94 M | 661.37% |
2017-12-31 | ยฃ1.43 M |